Factors affecting the quality of life of hypertensive patients

Eastern Mediterranean Health Journal

Volumn 11, Issue 1-2, 2005, Pages 109-118

  Youssef, Randa M ^a   Moubarak, I I ^a   Kamel, M I ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; COMORBIDITY; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEMOGRAPHY; DRUG DOSE REGIMEN; EMOTIONALITY; FEMALE; HEALTH STATUS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZATION; SIDE EFFECT; SOCIOECONOMICS;

ACTIVITIES OF DAILY LIVING; ADAPTATION, PSYCHOLOGICAL; AGED; ANTIHYPERTENSIVE AGENTS; ATTITUDE TO HEALTH; COMORBIDITY; DRUG ADMINISTRATION SCHEDULE; EGYPT; FEMALE; HEALTH STATUS; HEALTH STATUS INDICATORS; HEALTH SURVEYS; HUMANS; HYPERTENSION; MALE; MENTAL HEALTH; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; SOCIOECONOMIC FACTORS; URBAN HEALTH;

EID: 33644601448     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Clark NM. Understanding individual and collective capacity to enhance quality of life. Health education & behavior, 2000, 27(6):699-707.
2. Selke B, Marquis P, Lebrun T. Les repercussions socio-économiques et de qualité de vie de l'hypertension arterielle. [Socioeconomic and quality of life repercussions of arterial hypertension]. Drugs, 1998, 56(suppl. 2):45-53.
3. Weber MA, Radensky P. Measurement of short-term, intermediate, and long-term outcomes of treating hypertension. Cardiology clinics, 1996, 14(1):131-42.
4. Stewart AL et al. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. Journal of the American Medical Association, 1989, 262(7):907-13.
5. Plaisted CS et al. The effects of dietary patterns on quality of life: a substudy of the Dietary Approaches to Stop Hypertension trial. Journal of the American Dietetic Association, 1999, 99(suppl. 8): S84-9.
6. Wiklund I. Quality of life and cost-effectiveness in the treatment of hypertension. Journal of clinical pharmacy and therapeutics, 1994, 19(2):81-7.
7. Lawrence WF et al. Health status and hypertension: a population based study. Journal of clinical epidemiology, 1996, 49:1239-45.
8. Robbins MA et al. Unmedicated blood pressure levels and quality of life in elderly hypertensive women. Psychosomatic medicine, 1994, 56:251-9.
9. Anderson RB, Hollenberg NK, Williams GH. Physical Symptoms Distress Index: a sensitive tool to evaluate the impact of pharmacological agents on quality of life. Archives of internal medicine, 1999, 159(7):693-700.
10. Testa MA. Methods and applications of quality-of-life measurement during antihypertensive therapy. Current hypertension reports, 2000, 2(6):530-7.
11. Hypertension Health Status Inventory, Quality of Life Instruments Database, Mapi Research Trust, Lyon, France (http://www.qolid.org/public/HYPER.html, accessed 25 January 2005).
12. Youssef RM, Moubarak II. Patterns and determinants of treatment compliance among hypertensive patients. Eastern Mediterranean health journal, 2002, 8(4/5):579-92
13. Centers for Disease Prevention and Control. Community indicators of health related quality of life - United States, 1993-1997. Morbidity and mortality weekly report, 2000, 49:281-5.
14. Girvin B, Johnston D. The implication of non-compliance with antihypertensive medication. Drugs, 1996, 52(2):186-95.
15. McInnes GT. Integrated approach to management of hypertension: promoting treatment acceptance. American heart journal, 1999, 138(3Pt2):S252-5.
16. Dahlöf B et al. Main results of the losartan versus amlodipine (LOA) study on drug tolerability and psychological general well-being. Journal of hypertension, 1997, 15:1327-35.
17. Weir MR et al. Efficacy, tolerability, and quality of life of losartan, alone or with hydrochlorothiazide, versus nifedipine GITS in patients with essential hypertension. Clinical therapeutics, 1996, 18: 411-28.
18. Omvik P et al. Evaluation and quality-of-life assessment of amlodipine and enalapril in patients with hypertension. Journal of human hypertension, 1995, 9(suppl. 1):S17-24.
19. Constant P. Quatre facteurs contribuent à la qualité de vie de l'hypertendu. Quotidien du médicine, 1996, 5838:21.
20. Testa MA et al. Quality of life and antihypertensive therapy in men. A comparison of captopril with enalapril. The Quality-of-Life Hypertension Study Group. New England journal of medicine, 1993, 328:907-13.